DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20171769

An epidemiological study to find out the seroprevalence of Hepatitis B in a rural population of Kashmir valley

Anjum Bashir Fazili, Rohul Jabeen Shah, Zaffar Amin Shah, Qazi Mohammad Iqbal, Beenish Mushtaq, Feroz Ahmad, Javed Ahmad Parray

Abstract


Background: Hepatitis B continues to pose a tremendous burden of disease with approximately 240 million people having chronic hepatitis B virus (HBV) infection globally. The prevalence of HBV infection varies widely, with rates ranging from 0.1% to 20% in different parts of the world.

Methods: This Community based Cross sectional study was carried out for a period of one year (2015-2016) in bock Hajin of Kashmir to find out the seroprevalence of Hepatitis B and various risk factors associated with it.1861 subjects consented and participated in the study. A semi structured, pre tested, self-designed questionnaire was used to gather requisite information. Both screening as well as confirmatory tests were used to find out the seroprevalence of HBsAg in the study population.

Results: Out of 1861 participants, 65.1% were females and 34.9% were males. All study participants were Muslims with 64.4% belonging to Sunni sec. 67.3% belonged to age group 10-40 years. Prevalence of hepatitis B infection in the study population was 0.9%. Gender, occupation, education and treatment by quacks were significantly associated with seropositivity. Only 76 (4.1%) of the participants had some knowledge about hepatitis B.

Conclusions: The study reveals that the seroprevalence of hepatitis B is very low in the study population. It also reflects a low awareness level of population regarding hepatitis B infection thus demanding timely intervention in the form of awareness campaigns to keep transmission under check.


Keywords


Hepatitis B, Seroprevalence, Risk factors

Full Text:

PDF

References


WHO: Hepatitis B fact sheet; 2016.

WHO core programme clusters. Family and Community health. Hepatitis B. Community Office for India. (http://www.whoindia.org/en/section6 section8.htm. Accessed on 2 February 2017.

Bonino F, Chiaberge E, Maran E, Piantino P. Serological marker of HBV infectivity. Ann Ist Super Sanita.1987;24(2):217-23.

Nair SPR. Hepatitis B and D. In: BT ZD, editor. Hepatology. 4th ed. Philadelphia: WB Sunders; 2003: 956-1016.

Kochhar A, Singh K, Kochhar S, Duggal G, Choudhary S, Pandey S. A Study To Assess Trend In Seroprevalence Of Hepatitis B Virus Infection Among Blood Donors of Southern Haryana, India. Int J Path. 2012;13(2):1-4.

Kurien T, Thyagarajan SP, Jeyaseelan L, Peedicayil A, Rajendran P, Sivaram S, Hansdak SG, Renu G, Krishnamurthy P, Sudhakar K,Varghese JC. Community prevalence of hepatitis B infection and modes of transmission in Tamil Nadu, India. Indian J Med Res. 2005;121(5):670-5.

Dienstag JL, Isselbacher KJ. Acute viral Hepatitis. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, editors. Harrisons Principles of Internal Medicine. New York: Mc Graw Hill; 1998: 1677-1692.

NCDC Newsletter. Quarterly Newsletter from the National Centre for Disease Control (NCDC); 2014;3(10).

Prasad B, Naimish S, Pathik P, Meghraj I, Aniruddha P, Prabha S. Cross sectional study of prevalence and risk factors of hepatitis b and hepatitis c infection in a rural village of INDIA Arq Gastroenterol. 2015;52(4):321-4.

Irfa N, Syed YAQ, Nighat Y, Nighat B. Seroprevalence and Risk Factors of Hepatitis B Virus Infection among General Population of Srinagar Kashmir Int J Cont Med Res. 2016;3(4):1050-4.

Quadri SA, Dadapeer HJ, Arifulla KM, Khan N. Prevalence of Hepatitis B Surface Antigen in hospital based population in Bijapur, Karnataka. Al Ameen J Med Sci. 2013;6 (2):180-2.

Mohd A, Mohd Z, Abdul HA. Assessment of awareness of hepatitis B virus infection in the patients attending NIUM Banglore, India. Int Res J Pharm. 2015;6(3):210-2

Wang Y, Zhang W, Zhang Z, Ma J, Yu H, Shao H, et al. A community-based seroepidemiological survey of hepatitis B among adults in Chaoyang district, Beijing. Zhonghua Liu Xing Bing Xue Za Zhi. 2015;36(10):1104-8.

Khosravani A, Sarkari B, Negahban Ha, Sharifi A, Akbartabar TM, Khosravani EO, et al. Hepatitis B Infection among high risk population: A seroepidemiological survey in Southwest of Iran. BMC Infectious Diseases. 2012;12:378.

Motta-Castro ARC, Yoshida CFT, Lemos ERS, Oliveira JM, Cunha RV, Lewis-Ximenez LL, et al. Seroprevalence of Hepatitis B Virus Infection among an Afro descendant Community in Brazil Mem Inst Oswaldo Cruz, Rio de Janeiro. 2003;98(1):13-7.

Patil SR, Ghorpade MV, Patil SS, Pawar SK, Mohite ST. Seroprevalence of Hepatitis-B surface antigen among the patients reporting at tertiary care Hospital from India , Bangladesh Journal of Medical Science. 2016;15 (03):455-9.

Brouard C, Gautier A,Saboni L, Jestin C, Semaille C, Beltzer N. . Hepatitis B knowledge, perceptions and practices in the French general population: the room for improvement and for the KABP France group BMC Public Health.2013;13:576

Chung PW, Suen SH, Chan OK, Lao TH, Leung TY. Awareness and knowledge of hepatitis B infection and prevention and the use of hepatitis B vaccination in the Hong Kong adultChinese population. Chin Med J (Engl). 2012;125(3):422-7.

Naqshbandi I, Qadri SY, Bashir N, Yasmeen N. Hepatitis B Knowledge and Vaccination Status among Ethnic Kashmiri Population: A Community Based Cross-Sectional Study. IMJ Health medical journal research. 2015;1(9).27-34.

Taylor VM, Talbot J, Do HH, Liu Q, Yasui Y, Jackson JC, Bastani R.Hepatitis B Knowledge and Practices among Cambodian Americans. Asian Pac J Cancer Prev. 2011;12(4):957-61.

Amidu N, Alhassan A, Obirikorang C, Feglo P, Majeed SF, Afful D. Sero-prevalence of hepatitis B surface (HBsAg) antigen in three densely populated communities in Kumsani,Ghana. J Med Bio Sci. 2012;1(2):59-65.

Mustafa AAA, Yassir ME, Abdelwahid SA. Seroprevalence of Hepatitis B virus and Hepatitis C virus among blood donors in Nyala, South Dar Fur. Sudan Virology Journal. 2009;6:146.

Sood S, Malvankar S. Seroprevalence of Hepatitis B surface antigen, antibodies to the Hepatitis C virus, and human immunodeficiency virus in a hospital-based population in Jaipur, Rajasthan. Indian J Community Med. 2010;35:165- 9.

Jagannathan L, Chaturvedi M, Mudaliar S, Kamaladoss T. NIH Public Access. 2011;20:414–20.

Ghadir MR, Belbasi M, Heidari A, Jandagh M, Ahmadi I, Habibinejad H, et al. Distribution and risk factors of hepatitis B virus infection in the general population of Central Iran. Hepatitis monthly. 2012;12:112–7.

Xiaoqing L, Yingjun Z, Adrian L, Biao C, Dongqing Y, Feng H, et al.. Hepatitis B virus infections and risk factors among the general population in Anhui Province, China: an epidemiological study. BMC Public Health. 2012,12:272.

Pereira LMMB, Martelli CMT, Merchán-Hamann E, Montarroyos UR, Braga MC, de Lima MLC, et al. Population-based multicentric survey of hepatitis B infection and risk factor differences among three regions in Brazil. Am J Trop Med Hyg. 2009;81:240–7.

Qureshi H, Arif A, Riaz K, Alam SE, Ahmed W, Mujeeb SA. Determination of risk factors for hepatitis B and C in male patients suffering from chronic hepatitis. BMC research notes. 2009;2:212.

Li X, Zheng Y, Liau A, Cai B, Ye D, Huang F, et al. Hepatitis B virus infections and risk factors among the general population in Anhui Province, China: an epidemiological study. BMC public health. BioMed Central Ltd. 2012;12:272.